SCHEMBL4673723

SCHEMBL4673723

COC(=O)C(C)NS(=O)(=O)N1CCN(c2ccc(Cl)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
MAPT P10636 8/20 0.50
TP53 P04637 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
MMP14 P50281 1/20 0.47
ADAMTS5 Q9UNA0 1/20 0.47
HSD11B1 P28845 1/20 0.43
GAA P10253 1/20 0.43
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
CCR1 P32246 1/20 0.41
POLB P06746 1/20 0.41
ACLY P53396 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673727 1.00 MEN1 (0.52) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL13591200 0.89 MEN1 (0.49) MEN1KMT2AMAPTSMN1; SMN2HSD11B1
SCHEMBL4673480 0.88 MAPT (0.48) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL4673477 0.88 MAPT (0.48) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL13392218 0.88 MAPT (0.44) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL13392207 0.88 AKR1C3 (0.40) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL4673962 0.87 MMP14 (0.52) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL4671242 0.87 MMP14 (0.52) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL4671248 0.87 MMP14 (0.52) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL13392220 0.87 ALDH1A1 (0.47) MEN1KMT2AMAPTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed